South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that...
Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced ...
A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cance...
South Korea-based Crescom, a company specialising in musculoskeletal medical artificial intelligence (AI), has signed a ...
US-based Pillar Biosciences, Inc., LC-SCRUM-Asia and LSI Medience Corporation have announced a collaboration to support ...
Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced the launch o...
UK-based Optellum and South Korea's Coreline Soft have announced their intent to collaborate across geographie...
For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
Co-Diagnostics, Inc., a US-based molecular diagnostics company with a unique, patented platform for the development of m...
Japan's Global Health Innovative Technology (GHIT) Fund has announced an investment of JPY 140 million (approximately $8...
As Malaysia confronts a significant surge in Tuberculosis (TB) cases, with over 3,100 confirmed infections recorded in t...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
Virax Biolabs has announced that its wholly owned subsidiary, Virax Biolabs (UK) has entered into an exclusive multi-cou...
Seegene has announced the launch of the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility an...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
Thailand is entering a diagnostics renaissance, shifting from illness confirmation within hospitals to early diagnosis t...
Having worked across the Asia-Pacific (APAC) region in molecular diagnostics, I am often asked which country is ‘w...
Diagnostics has become one of the fastest-evolving segments of healthcare in Asia-Pacific. For decades, the region's dia...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has re...
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...
